Ireland
--:--IST
Latest
Clinical Trials in Spain / NCT07694141
Recruiting Observational

Postoperative Analgesia in Thoracic Surgery

NCT07694141 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2025-11-15
Last updated
2026-07-20

Condition(s) studied

Postoperative Pain Management

Investigational drug(s) / intervention(s)

Postoperative pain through Visual analogue scalePostoperative complications

Postoperative pain through Visual analogue scale: Postoperative pain will be assessed using the visual analog pain scale at 1, 3, 6, 24, and 48 hours postoperatively.

Postoperative complications: The patient's postoperative evolution will be assessed until hospital discharge, in order to define the appearance of postoperative complications classified according to Clavien-Dindo classification.

Study summary

Analgesic management in thoracic surgery presents a particular challenge for the anesthesiologist, given the intensity of postoperative pain associated with thoracotomy, a surgical procedure that can impact respiratory function and the patient's subsequent recovery. Epidural analgesia is the gold standard. When epidural catheter placement is not feasible, erector spinae plane block is a safe alternative. The ultrasound target is easily visualized, and the injection site is far from the neuraxis, pleura, and major vascular structures. Consequently, this block has been incorporated into standard clinical practice as a treatment option for patients with complex cases or as an alternative approach when epidural catheter placement is not feasible. The primary objective of this study is to assess the effectiveness of postoperative analgesia in patients undergoing elective thoracic surgery.

Study Population Design A prospective observational follow-up study will be conducted. ASA I-III patients undergoing scheduled thoracic surgery between November 1 and December 31, 2025, will be included. Their analgesic management will be based on standard clinical practice.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients undergoing thoracic surgery between July 1 and October 31, 2020. * Age over 18. * ASA I-III. * Signed informed consent Exclusion Criteria: * ASA IV-V. * Chronic opioid treatment or treatment in the Chronic Pain Unit. * Intravenous drug abuse. * Local anesthetic allergy. * Language barrier, cognitive impairment, or inability to participate in clinical assessment during the study. * BMI \<18 or \>35 kg/m2

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital Universitario de Gran Canaria Doctor Negrín Las Palmas de Gran Canaria Las Palmas Recruiting

More Hospital Universitario de Gran Canaria Doctor Negrín trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07694141 on ClinicalTrials.gov ↗ ← All trials in Spain